Bellevue F.(L)-B.Obesity Sol.I2 EUR/ LU1725387622 /
| NAV2024-04-24 | Chg.-0.0300 | Type of yield | Investment Focus | Investment company |
|---|---|---|---|---|
| 164.1300EUR | -0.02% | reinvestment | Equity Worldwide | Waystone M.Co.(Lux) ▶ |
Monthly performance
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2017 | - | - | - | - | - | - | - | - | - | - | - | 0.29 | - |
| 2018 | 3.97 | -3.52 | -1.38 | -3.60 | 7.70 | 0.11 | 5.95 | 5.65 | -1.10 | -14.23 | 4.04 | -11.53 | -10.14% |
| 2019 | 12.69 | 5.11 | 2.41 | -6.49 | -3.71 | 6.90 | 0.78 | -2.04 | -2.50 | 4.18 | 12.70 | -0.49 | +31.31% |
| 2020 | -4.25 | -1.18 | -7.87 | 15.04 | 8.38 | 2.83 | -6.21 | 0.00 | 1.54 | -3.42 | 8.97 | 1.59 | +13.81% |
| 2021 | 5.22 | -2.29 | -2.40 | 1.71 | -0.49 | 8.25 | 3.10 | 2.55 | -3.98 | -0.02 | -1.26 | -0.67 | +9.44% |
| 2022 | -10.90 | -3.22 | 6.18 | -3.15 | -4.05 | 4.38 | 6.34 | -0.97 | 0.99 | 5.83 | 2.00 | -7.37 | -5.56% |
| 2023 | 0.40 | -4.42 | -1.26 | 0.40 | 1.48 | -2.80 | -0.68 | 0.47 | -1.60 | -6.72 | 0.44 | 0.99 | -12.82% |
| 2024 | 4.25 | 3.76 | 2.74 | -2.65 | - | - | - | - | - | - | - | - | - |
Calculated values
| YTD | 6 Months | 1 Year | 3 Years | 5 Years | |
|---|---|---|---|---|---|
| Volatility | 9.76% | 12.33% | 13.01% | 19.50% | 22.74% |
| Sharpe ratio | 2.57 | 0.75 | -0.49 | -0.30 | 0.06 |
| Best month | +4.25% | +4.25% | +4.25% | +8.25% | +15.04% |
| Worst month | -2.65% | -6.72% | -6.72% | -10.90% | -10.90% |
| Maximum loss | -4.47% | -5.29% | -15.45% | -27.01% | -29.19% |
| Outperformance | -2.75% | - | -1.14% | - | - |
All quotes in EUR
Tranches
| Name | Type of yield | Repurchase p. | 1 Year | 3 Years | |
|---|---|---|---|---|---|
| Bellevue F.(L)-B.Obesity Sol.I2 ... | reinvestment | 164.1300 | -2.44% | -5.54% | |
| Bellevue F.(L)-B.Obesity Sol.I U... | reinvestment | 560.2400 | -5.59% | -16.79% | |
| Bellevue F.(L)-B.Obesity Sol.I E... | reinvestment | 702.0000 | -2.57% | -5.94% | |
| Bellevue F.(L)-B.Obesity Sol.I C... | reinvestment | 451.2800 | -2.92% | -16.81% | |
| Bellevue F.(L)-B.Obesity Sol.I G... | reinvestment | 476.1700 | -5.36% | -7.03% | |
| Bellevue F.(L)-B.Obesity Sol.B U... | reinvestment | 502.3100 | -6.25% | -18.52% | |
| Bellevue F.(L)-B.Obesity Sol.B C... | reinvestment | 402.4300 | -3.60% | -18.54% | |
| Bellevue F.(L)-B.Obesity Sol.B E... | reinvestment | 627.0900 | -3.26% | -7.89% |
Performance
| YTD | +8.19% | ||
|---|---|---|---|
| 6 Months | +6.36% | ||
| 1 Year | -2.44% | ||
| 3 Years | -5.54% | ||
| 5 Years | +29.05% | ||
| Since start | +31.30% | ||
| Year | |||
| 2023 | -12.82% | ||
| 2022 | -5.56% | ||
| 2021 | +9.44% | ||
| 2020 | +13.81% | ||
| 2019 | +31.31% | ||
| 2018 | -10.14% | ||
